-
CENTRES
Progammes & Centres
Location
53 results found
लोकसंख्येचे वय जसजसे वाढत जाते, तसतसे देश त्यांचा प्रभाव
जैसे-जैसे उम्रदराज़ लोगों की संख्या बढ़ रही है, वैसे-वैसे
As aging populations grow, nations turn to longevity diplomacy—using health policies, biotech, and therapeutics to enhance soft power and global lea
अमेरिकेच्या निर्बंधांनी अनवधानाने चीनला संशोधन व विकास
अमेरिकी प्रतिबंधों ने अनायास ही चीन को अपने अनुसंधान व व�
The US restrictions have inadvertently spurred China to accelerate R&D and innovation, allowing it to challenge Western dominance
एंटीबायोटिक प्रतिकारशक्तीची गुंतागुंतीची समस्या केवळ �
The complex problem of antimicrobial resistance needs to be combated with a coordinated strategy, supported by governmental and cross-sector collabora
The collaboration between space research and biotechnology can both improve the health of space travellers and also aid with new research and innovati
मानसिक आरोग्यविषयक संकटाशी प्रभावीपणे सामना करण्यासाठ�
India must prioritise the development of novel drugs to address the mental health crisis effectively, leveraging its biotechnology and pharmaceutical
There is a growing need to harness miRNA biology to develop new technologies and focus on its translational applications
अमेरिकेचा बायोसिक्युअर कायदा त्या देशाच्या चीनशी असलेल
जैवतंत्रज्ञानाच्या प्रगतीमधली गुंतागुंत आणि संभाव्य ज�
‘आयसीईटी’अंतर्गत बायोसिक्युरिटी आणि बायोसेफ्टी या दोह�
Given the complexity and potential risks associated with the biotechnological advancements, India should establish a dedicated biosecurity agency to a
The US Biosecure Act aims to decouple its supply chains from China, presenting a huge opportunity for India’s pharma industry
Enhanced collaboration between the US and India on biosecurity and biosafety under iCET could be highly advantageous
.png)
Advancements in biotechnology and accessible dual-use technologies have raised concerns about non-state actors gaining unregulated access to biologica
চিন–রাশিয়া জৈবপ্রযুক্তি সহযোগিতা, যা ফার্মাসিউটিক্যা�
चीनी-रशियन बायोटेक्नॉलॉजीच्या सहकार्यामुळे फार्मास्य�
कृत्रिम बुद्धिमत्ता (AI) आणि जैवतंत्रज्ञान यांच्यातील सम�
फार्मास्यूटिकल्स और आर्थिक वृद्धि पर रणनीतिक ज़ोर के बू�
The Sino-Russian biotechnology collaboration, augmented by its strategic focus on pharmaceuticals and economic growth, has called for a global concern
While addressing aspects of the synergy between Artificial Intelligence (AI) and biotechnology, the existing regulatory landscape will need more expli
जैसे जैसे जैव प्रौद्योगिकी का उद्योग विकसित हो रहा है, वै�
As the biotechnology industry evolves, integrating synthetic data and model-based reasoning will remain crucial for addressing complex biological chal
As genetic engineering continues to grow and find more avenues of impact, the need to optimise and regulate this technology will also heighten
Indian tech startups are confronting huge roadblocks as funding runs low
अपनी स्थापना के साथ ही जैव प्रौद्योगिकी विभाग ने खुद को स�
As the ecosystem evolves and companies mature, there are dire requirements for the next phase of innovation driven growth.
Since its inception, DBT has been committed to delivering solutions for societal challenges with a focus on Make in India.
Advances in disruptive technologies have enabled scientists to engineer biological systems and create more efficient and sustainable products for a range of purposes. The convergence of artificial intelligence (AI) with biotechnology has contributed to the development of therapeutics and vaccines, helped address food security, aided in generating innovative processes to mitigate the effects of climate change, and expanded the bioeconomy. However,
This brief analyses the regulatory, security and ethical challenges facing states and the international community regarding emerging technologies in biotechnology, focusing on the CRISPR/Cas9 gene editing system and artificial gene synthesis. It highlights the inadequacy of current mechanisms such as export control regimes to regulate these emerging technologies because of a fundamental shift in the nature of challenges posed and an altered globa
Chennai may have lost out on the petroleum, petro-chemicals, pharmaceutical, and biotech fields, but it still remains the home-base of several solid market leaders from myriad industries.
The treatment of mental health disorders is a difficult task due to the highly subjective nature of each case, the varying efficacy of drugs available, and the social stigma associated with mental illness. In India, the treatment gap is steep, but it can be reduced in a number of ways: through concerted efforts by the biotechnology and pharmaceutical industries on novel drug development; by leveraging allied technologies such as data science, art
India’s growing strategic importance as a balance to China in the Indo-Pacific region, as well as convergence between New Delhi and Washington DC about Beijing’s aggressive stance on emerging technology, have resulted in warming relations between the United States (US) and India. Indeed, in recent years, there has been a spur of cooperative agreements between the two sides on domains such as defence technology, 5G, and semiconductors. This br
.png)
Various vaccine trials across the world are showing highly promising efficacy, and multiple vaccines are getting approved across continents. The global vaccine race has now entered its second phase, where countries try and procure as many doses of Covid-19 vaccines as possible. India has put its faith primarily in the vaccines of Oxford-AstraZeneca and Bharat Biotech-ICMR. It has also secured future stockpiles of Gamaleya and Novavax vaccines thr
In the biomedical field, laboratories must ensure biosafety while managing pathogens and microorganisms in order to protect personnel and the broader community against potential leaks and lab-acquired infections. Global standards provide a roadmap for the biosafety of laboratories, underscoring the importance of their design and equipment, personnel training, waste management, and communication in preventing potential biohazards from breaching co
Biological weapons can come from naturally occurring microbes and viruses; but innovations in genomic editing are opening up new, potentially more threatening avenues for their development. These innovations can cause or spread disease or resist known therapeutic approaches. Addressing such threats of biowarfare requires obtaining reliable and informative taxonomies for the pathogens and timely and effective responses. This, in turn, calls for co
The rapid development of genetic engineering technologies has created multiple opportunities for treating genetic diseases and improving human health. However, genetic engineering technology poses ethical, societal, and security challenges. This brief explores these risks, focusing on those related to genetically modified organisms (GMOs) and the revival of ideologies that consider some races to be “more suitable” than others. The brief also
Biotechnology emerging as a major element in global power equations
